Osaic Holdings’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $23.6K | Sell |
11,872
-128
| -1% | -$255 | ﹤0.01% | 5233 |
|
2025
Q1 | $16.9K | Buy |
12,000
+128
| +1% | +$180 | ﹤0.01% | 5424 |
|
2024
Q4 | $23.6K | Hold |
11,872
| – | – | ﹤0.01% | 5206 |
|
2024
Q3 | $37.4K | Buy |
11,872
+1,000
| +9% | +$3.15K | ﹤0.01% | 4925 |
|
2024
Q2 | $34.4K | Buy |
10,872
+2,872
| +36% | +$9.08K | ﹤0.01% | 4938 |
|
2024
Q1 | $35.9K | Sell |
8,000
-6,000
| -43% | -$26.9K | ﹤0.01% | 4950 |
|
2023
Q4 | $23.2K | Sell |
14,000
-8,629
| -38% | -$14.3K | ﹤0.01% | 5406 |
|
2023
Q3 | $20.3K | Buy |
22,629
+11,465
| +103% | +$10.3K | ﹤0.01% | 5531 |
|
2023
Q2 | $24K | Buy |
11,164
+1,682
| +18% | +$3.62K | ﹤0.01% | 5430 |
|
2023
Q1 | $18.5K | Buy |
9,482
+2,898
| +44% | +$5.65K | ﹤0.01% | 5595 |
|
2022
Q4 | $25K | Buy |
6,584
+1,327
| +25% | +$5.04K | ﹤0.01% | 5401 |
|
2022
Q3 | $25K | Sell |
5,257
-226
| -4% | -$1.08K | ﹤0.01% | 5388 |
|
2022
Q2 | $44K | Buy |
5,483
+2,235
| +69% | +$17.9K | ﹤0.01% | 5044 |
|
2022
Q1 | $47K | Buy |
3,248
+3,011
| +1,270% | +$43.6K | ﹤0.01% | 5125 |
|
2021
Q4 | $5K | Sell |
237
-105
| -31% | -$2.22K | ﹤0.01% | 6508 |
|
2021
Q3 | $9K | Sell |
342
-50
| -13% | -$1.32K | ﹤0.01% | 6246 |
|
2021
Q2 | $9K | Buy |
392
+211
| +117% | +$4.84K | ﹤0.01% | 6102 |
|
2021
Q1 | $5K | Hold |
181
| – | – | ﹤0.01% | 6077 |
|
2020
Q4 | $6K | Buy |
181
+16
| +10% | +$530 | ﹤0.01% | 5635 |
|
2020
Q3 | $5K | Sell |
165
-14
| -8% | -$424 | ﹤0.01% | 5504 |
|
2020
Q2 | $8K | Buy |
+179
| New | +$8K | ﹤0.01% | 5223 |
|